- Home
- ZLAB vs ACLS Comparison
ZLAB vs ACLS Comparison
Compare ZLAB & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- ACLS
- Stock Information
- Founded
- ZLAB 2013
- ACLS 1995
- Country
- ZLAB China
- ACLS United States
- Employees
- ZLAB N/A
- ACLS N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- ACLS Industrial Machinery/Components
- Sector
- ZLAB Health Care
- ACLS Technology
- Exchange
- ZLAB Nasdaq
- ACLS Nasdaq
- Market Cap
- ZLAB 3.2B
- ACLS 2.6B
- IPO Year
- ZLAB 2017
- ACLS 2000
- Fundamental
- Price
- ZLAB $20.98
- ACLS $79.91
- Analyst Decision
- ZLAB Buy
- ACLS Buy
- Analyst Count
- ZLAB 6
- ACLS 7
- Target Price
- ZLAB $57.22
- ACLS $98.80
- AVG Volume (30 Days)
- ZLAB 899.6K
- ACLS 650.3K
- Earning Date
- ZLAB 11-06-2025
- ACLS 11-04-2025
- Dividend Yield
- ZLAB N/A
- ACLS N/A
- EPS Growth
- ZLAB N/A
- ACLS N/A
- EPS
- ZLAB N/A
- ACLS 4.25
- Revenue
- ZLAB $441,629,000.00
- ACLS $853,135,000.00
- Revenue This Year
- ZLAB $40.71
- ACLS N/A
- Revenue Next Year
- ZLAB $50.42
- ACLS $5.53
- P/E Ratio
- ZLAB N/A
- ACLS $18.95
- Revenue Growth
- ZLAB 24.14
- ACLS N/A
- 52 Week Low
- ZLAB $20.61
- ACLS $40.40
- 52 Week High
- ZLAB $44.34
- ACLS $102.93
- Technical
- Relative Strength Index (RSI)
- ZLAB 21.54
- ACLS 41.98
- Support Level
- ZLAB $21.59
- ACLS $78.66
- Resistance Level
- ZLAB $22.28
- ACLS $88.37
- Average True Range (ATR)
- ZLAB 0.86
- ACLS 4.08
- MACD
- ZLAB -0.18
- ACLS -0.07
- Stochastic Oscillator
- ZLAB 6.41
- ACLS 12.30
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.